KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors.
about
Expression of KIT receptor tyrosine kinase in endothelial cells of juvenile brain tumorsOverexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progressionFunctional deregulation of KIT: link to mast cell proliferative diseases and other neoplasmsEvasion mechanisms to Igf1r inhibition in rhabdomyosarcomaComprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1RHigh-resolution array-based comparative genomic hybridization of medulloblastomas and supratentorial primitive neuroectodermal tumors.Expression of c-kit receptor in human cholangiocarcinoma and in vivo treatment with imatinib mesilate in chimeric miceExpression of proto-oncogene KIT is up-regulated in subset of human meningiomasTreatment of gastrointestinal stromal tumor: focus on imatinib mesylate.Therapeutic efficacy of c-kit-targeted radioimmunotherapy using 90Y-labeled anti-c-kit antibodies in a mouse model of small cell lung cancer.Gastrointestinal Stromal Tumors (GIST): A Prospective Analysis and an Update on Biomarkers and Current Treatment Concepts.An update on molecular genetics of gastrointestinal stromal tumours.An immunohistochemical and molecular genetic analysis of KIT and PDGFRA in small cell lung carcinoma in Japanese.Contrasting origin of B chromosomes in two cervids (Siberian roe deer and grey brocket deer) unravelled by chromosome-specific DNA sequencingSmall cell carcinoma of the urinary bladderPrevalence, clinico-pathological value, and co-occurrence of PDGFRA abnormalities in diffuse gliomas.Pathologic diagnosis of large cell neuroendocrine carcinoma of the lung in an axillary lymph node: a case report with immunohistochemical and molecular genetic studies.Diagnostic criteria, specific mutations, and genetic predisposition in gastrointestinal stromal tumors.KIT (CD117) Expression in Benign and Malignant Sweat Gland Tumors.Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression.Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest OncolAmelanotic malignant melanoma of the esophagus: report of two cases with immunohistochemical and molecular genetic study of KIT and PDGFRA.Concurrent occurrence of adenoid cystic carcinoma of the salivary glands with small cell carcinoma of the liver: A rare case report.Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlationsExpression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomyNCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies.The Frequency of Mutations in Exon 11 of the c-kit Gene in Patients With Leukemia.KIT and platelet-derived growth factor receptor α gene expression in laryngeal small cell carcinoma.Esophageal combined carcinomas: Immunohoistochemical and molecular genetic studies.Histopathologic study of the rectum in 1,464 consecutive rectal specimens in a single Japanese hospital: II. malignant lesions.Small cell carcinoma of the oral cavity (cheek mucosa): a case report with an immunohistochemical and molecular genetic analysis.Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy.Abdominal monophasic synovial sarcoma is a morphological and immunohistochemical mimic of gastrointestinal stromal tumour.Small cell neuroendocrine carcinoma of the esophagus: report of 6 cases with immunohistochemical and molecular genetic analysis of KIT and PDGFRA.Clonal trisomy 4 cells detected in the ossifying renal tumor of infancy: study of 3 cases.Small cell neuroendocrine carcinoma of the prostate: incidence and a report of four cases with an examination of KIT and PDGFRA.Expression of platelet-derived growth factor receptor in low-grade endometrial stromal sarcomas in the absence of activating mutations.Immunohistochemical and mutational analysis of PDGF and PDGFR in desmoid tumours: is there a role for tyrosine kinase inhibitors in c-kit-negative desmoid tumours?microRNA expression signatures of gastrointestinal stromal tumours: associations with imatinib resistance and patient outcome.
P2860
Q24614629-C7F4B468-79D8-4084-9A18-DC41B24AED28Q24813774-2D9477C1-56DB-430B-9B11-51E7C74C44AFQ26995624-CD4A73BC-A154-4806-9D74-FD563EA06A53Q30411769-2DB12CCD-A7C3-441F-8ECC-99DC99905A17Q30425784-CB68EC8A-1D33-4789-8206-0D3198A57911Q33629786-83C70E57-5DEF-4E14-8781-4D8CB3E7B9ADQ34012590-E70DAF7E-A0B7-44D1-B05D-6BC48AFB24E2Q34294309-15CC5841-30BB-41B7-93C8-99CB0ED0F24BQ34596126-4A16CE86-BB94-4027-9637-FAF2735B1262Q34630373-1F704C61-48FD-442F-9E38-D7F3EF0759F4Q35679349-D4FCAA84-79FC-49C0-99E0-CBD2C030EC68Q35770066-A4646B32-436C-4B0B-A278-3B4F201042ABQ36003276-F2F0F6DB-507C-4888-9076-2A67B1E4DCB2Q36102296-D9FAE5FD-03D5-4461-9A4F-98A5F8EAE1A1Q36196742-23A2A5F9-8644-426B-BF49-8476FFEBD887Q36344757-DF61B255-117D-4343-B169-8DA50629F821Q36853469-53B8ED7B-EBB0-4048-9B12-3AA7B72DE878Q36925163-BEFC1694-2C56-4DE2-AA93-5DE45116265EQ36973465-903C38C8-FEAB-4110-A0E3-B3815132E713Q37042015-0987B28E-A27F-4997-AD9F-BD1D7D72CFE4Q37117099-9CEF590D-5FFF-4BCA-B27F-CC37A35F4D78Q37214631-FFC6117C-8E22-4746-94E5-3654A9273839Q37314440-C3D8DB5C-48BC-4719-9564-CCBEAC87249DQ37326191-A2E2D50F-A64E-4E59-B7B3-3A77341C1304Q37345320-97B9D811-04FC-42F0-9E92-2A7DB02F7A4CQ37350516-23E753E7-3E77-4E95-A2AB-EA0A5F20149FQ37590339-0298C9FC-8DBB-4795-BD1F-F3C72BB860AFQ37702830-9D17A9CB-9441-4FA0-97FB-53FACABC18A5Q37764098-8E7E8053-010C-4DC5-8934-C5A94CFA386AQ38003143-8AA380B6-AFB4-42E8-978F-A476C41245B1Q38081834-2D75DDE1-3230-4BA1-87C6-88F11E2B817FQ38097788-05A919B0-45CC-4982-817D-17475B49778BQ38193533-EE8909AF-2045-4737-9219-4E184139021DQ38262850-6496D413-A010-4A58-A12A-724B7119420BQ38398121-A6A697E2-6932-4A8F-B391-C2C1A1CB377DQ38401024-EC9CD166-AA0D-4795-A5F5-6AB82D6DE94DQ38406805-941A9920-7326-420D-A9EE-C9AACF753A17Q38432839-201C54ED-3EE3-4153-9DED-CCF7C3023842Q38434898-2A4C969F-C29C-4982-9380-8E04C438CE45Q38944612-E0CC396B-211E-4BC1-9828-5EE6C078B84D
P2860
KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
KIT and platelet-derived growt ...... cations in human solid tumors.
@en
KIT and platelet-derived growt ...... cations in human solid tumors.
@nl
type
label
KIT and platelet-derived growt ...... cations in human solid tumors.
@en
KIT and platelet-derived growt ...... cations in human solid tumors.
@nl
prefLabel
KIT and platelet-derived growt ...... cations in human solid tumors.
@en
KIT and platelet-derived growt ...... cations in human solid tumors.
@nl
P2093
P356
P1476
KIT and platelet-derived growt ...... cations in human solid tumors.
@en
P2093
Kaarle Franssila
Leif C Andersson
Maarit Sarlomo-Rikala
Minna Tanner
Nina N Nupponen
Olli Tynninen
P356
10.1200/JCO.2005.02.093
P407
P577
2004-11-15T00:00:00Z